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INTRODUCTION
Common image findings of breast metastases from extra-
mammary malignancy are single or multiple, round, usually 
circumscribed mass(es) variable in size (1). This is known 
to be due to a nonductal pattern of metastatic spread 
and lack of desmoplastic reaction in breast metastasis. 
If architectural distortion is seen on mammography, the 
possibility of metastasis from extra-mammary malignancy is 
very low and primary breast lesion including primary cancer 
is rather favored.
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A 47-year-old Korean woman with right middle lobe lung adenocarcinoma, malignant pleural effusion, and multiple lymph 
node and bone metastases, after three months of lung cancer diagnosis, presented with a palpable right breast mass. 
Images of the right breast demonstrated architectural distortion that strongly suggested primary breast cancer. Breast 
biopsy revealed metastatic lung cancer with a negative result for estrogen receptor (ER), progesterone receptor (PR) and 
mammaglobin, and a positive result for thyroid transcription factor-1 (TTF-1). We present a case of breast metastasis from a 
case of lung cancer with an extensive micropapillary component, which was initially misinterpreted as a primary breast 
cancer due to unusual image findings with architectural distortion.
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Here, we present a case of breast metastasis from lung 
cancer with extensive micropapillary component which was 
initially favored to be the primary breast cancer rather than 
metastasis because the breast lesion was associated with an 
architectural distortion on mammography.
CASE REPORT
A 47-year-old woman initially presented with chest 
pain and dyspnea for the last three months and with 
3 kg in weight loss over the last six months. Her past 
medical history includes a right thyroid lobectomy for 
a large benign thyroid nodule and cyst about two years 
ago. A chest computed tomography (CT) from the outside 
hospital showed a 2.3 x 1.8 cm sized mass in the right 
middle lobe with pleural effusion (Fig. 1A). On a positron 
emission tomography (PET) image, hot uptakes were noted 
at multiple sites including the main lung mass, multiple 
mediastinal and right cardiophrenic lymph nodes, and bones 
(ribs and right femoral head). 
Clinically, lung cancer with distant metastasis (clinical 
stage IV) was suspected and the patient was transferred to 
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our hospital. A lung biopsy was performed and a primary 
lung adenocarcinoma with predominantly micropapillary 
carcinoma component was diagnosed (Fig. 1B). The patient 
was treated with chemotherapy consisting of Cisplatin 
followed by Irinotecan.
Three months after the initiation of chemotherapy, 
she complained of a palpable mass in her right breast. 
For evaluation of the right breast lesion, she underwent 
mammography and spot magnification with metallic marker 
attachment (Fig. 1C). 
On the right lower inner quadrant, focal architectural 
distortion was detected without evidence of 
microcalcifications or mass on images. A follow-up chest CT 
shows an irregular enhancing lesion of the right breast in 
the lower inner quadrant (Fig. 1D). A breast ultrasound (US) 
was performed to localize the lesion and for a biopsy. The 
breast US showed an about 1 cm sized ill-defined irregular-
shaped isoechoic lesion in the right lower inner quadrant, 
about 4 cm from the right nipple (Fig. 1E). Color Doppler 
US demonstrated no vascularity. In order to confirm the 
image finding of primary breast cancer and to exclude the 
possibility of metastatic lung cancer, an US-guided core 
needle biopsy (14 gauge automated gun, Acecut®, TSK 
Laboratory, Tochigi, Japan) was performed and 4 core tissue 
samples were obtained. 
The breast biopsy showed an adenocarcinoma with a 
micropapillary component as well as a desmoplastic reaction 
and lymphovascular invasion, which was morphologically 
similar to that seen in the primary lung cancer (Fig. 1F). 
The surrounding breast ducts and lobules were unremarkable 
with no atypical changes. To further support the metastatic 
carcinoma from the lung and to exclude the primary 
breast cancer, immunohistochemistry was recommended. 
Immunohistochemical markers for breast including ER, PR, 
and mammaglobin, were negative and lung cancer marker 
of TTF-1 was strongly positive, which further supported the 
lung adenocarcinoma with metastasis to the breast. 
After 4 cycles of cisplatin followed by Irinotecan, the 
chemotherapeutic agent was changed to Erlotinib. Five 
months after performing an US-guided core biopsy of the 
right breast, the volume of the main lung mass and pleural 
effusion was minimally decreased and the patient’s dyspneic 
symptoms were relieved. She did not undergo any follow-
up examination for the breast lesion. She is currently alive 
with disease eight months after initial diagnosis of lung 
cancer.
 
DISCUSSION
In contrast to primary breast cancer being the most 
common malignancy of adult females worldwide, metastatic 
involvement of the breast is rare with a reported frequency 
of 0.4-1.3% in clinical series (2, 3). Despite its rarity, 
metastatic disease to the breast is an important diagnostic 
clinical problem, because its treatment differs greatly from 
that of primary breast cancer. 
Carcinomas with micropapillary components have 
been reported at several anatomical sites, including the 
breast, urinary bladder, ovary, major salivary glands, and 
recently the lungs (4). The micropapillary component 
is being increasingly recognized as a prognostic 
predictor for aggressive behavior with a tendency to 
metastasize to the lymph nodes and other organs (5, 
6). Maounis et al. (7) reported a case of metastasis to 
the breast from lung adenocarcinoma with an extensive 
micropapillary component, focused on the pathologic and 
immunohistochemical differentiation of the primary lung 
versus breast. To the best of our knowledge, our case is the 
second case of lung adenocarcinoma with a micropapillary 
component metastatic to the breast. Our case and Maounis 
et al.’s case shared some similarities in that they were more 
compatible with primary breast cancer than the metastasis 
on initial image findings. Based on the rare reported 
cases, it is difficult to document whether lung cancer 
with a micropapillary component has a unique pattern of 
breast metastasis or not on image findings. However, it 
is worthwhile to accumulate more cases to support our 
findings. 
The distinction between metastasis from lung 
adenocarcinoma, particularly with extensive micropapillary 
patterns, and primary mammary micropapillary 
adenocarcinoma may cause a significant diagnostic 
dilemma. The immunohistochemistry could contribute to a 
differential diagnosis. TTF-1 is expressed in 68-80% of lung 
adenocarcinoma cases, and has never been reported to stain 
positive in breast adenocarcinoma cases (8). ER expression 
in lung adenocarcinoma cases using monoclonal antibodies, 
is very low (9). Finally, mammaglobin is expressed in 48-
72% of mammary adenocarcinoma cases, but stains negative 
in pulmonary adenocarcinoma (8, 10). Consequently, a 
panel of markers must be used, as no single antibody is 
100% sensitive and false negative results do occur. The 
panel for distinguishing lung adenocarcinoma from breast 
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Fig. 1. Images and pathologic findings in 47-year-old woman with primary lung cancer.
A. Outside chest CT shows round mass with internal necrosis in right middle lobe (arrow), with right pleural effusion. B. Primary lung cancer 
shows adenocarcinoma with papillary and micropapillary carcinoma (arrow; Hematoxylin and Eosin staining, x 100). TTF-1 stain reveals nuclear 
positivity (inset, TTF-1 immunostaining, x 200). C. Spot compression view of right breast shows focal architectural distortion (arrow) in right 
lower inner quadrant without evidence of microcalcifications or discrete mass. Metallic marker is attached to area of palpable site. D. Follow-
up chest CT shows irregular enhancing lesion of right breast in lower inner quadrant (arrow). E. Breast US demonstrates 1 cm sized ill-defined 
irregular shaped isoechoic lesion (arrows) with focal infiltration at 4 o’clock position in right breast. F. Breast biopsy shows micropapillary 
carcinoma with small tumor cell nests in empty lacunar spaces and desmoplastic reaction in stroma (Hematoxylin and Eosin staining, x 100). TTF-
1 stain reveals nuclear positivity, supporting metastasis from lung (TTF-1 immunostaining, x 100).Korean J Radiol 13(2), Mar/Apr 2012 kjronline.org 252
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and TTF-1 for the lung. Our case demonstrated a typical 
immunohistochemical finding of lung cancer with ER, PR 
and mammaglobin negative, and TTF-1 positive.
Imaging findings of primary invasive micropapillary 
carcinoma of the breast are highly suggestive of malignancy. 
The lesion is known to be a high-density irregular mass 
with indistinct margins associated and microcalcifications 
on mammograms; a solid irregular hypoechoic mass with 
indistinct margins and frequent axillary nodal involvement 
on sonograms (11). In our case, microcalcifications were 
not seen on mammogram.
The most common radiologic appearance of blood-borne 
metastasis to the breast is one or more round, discrete 
nodules in the breast (12). From a purely radiologic view, 
these nodules cannot be differentiated from small benign 
nodules such as cysts or fibroadenomas. To differentiate 
radiologically metastatic carcinoma to the breast from the 
primary breast cancer, several points should be kept in 
mind. A discrete nodule in the mammography of patients 
known to have extra-mammary cancer should alert one 
to the possibility of blood-borne metastasis, particularly 
if other soft tissue metastases are also present. Likewise, 
an unusual or eccentric location of a discrete nodule in 
subcutaneous fat rather than glandular tissue should 
suggest the possibility of blood-borne metastasis. In 
addition, the rapid growth of breast nodules between 
two mammogram intervals may also be an important clue 
favoring metastasis (12). Another type of metastasis to the 
breast from extra-mammary malignancy is cross lymphatic, 
with the earliest radiologic finding of this type is skin 
thickening (12). 
In our case, the images did not indicate any mass or skin 
thickening. An architectural distortion was the main image 
finding. Therefore, the first impression was a primary breast 
malignancy even though the patient has a known history of 
lung adenocarcinoma. 
The histology of metastases to the breast usually 
reflects the primary tumor well enough that the pathologic 
diagnosis is obvious. The metastatic tumor in the breast 
in the current case revealed an adenocarcinoma with 
micropapillary component with severe desmoplastic reaction 
and lymphovascular invasion, which could be a possible 
explanation of the architectural distortion on images. 
This was a unique finding, different from that of another 
case report described as diffuse asymmetric density on 
mammography (13). 
We present a rare case of metastasis to the breast from 
lung adenocarcinoma with an extensive micropapillary 
component, which on mammography due to architectural 
distortion, a primary breast carcinoma was favored even 
though the patient had a history of known primary lung 
cancer and this pattern has never been described before 
as a metastasis. Therefore, in cases with architectural 
distortion on mammogram with known lung cancer history, 
before making the diagnosis of primary breast cancer, 
the possibility of metastasis from the known lung cancer 
should be carefully excluded, in addition to considering the 
presence of a micropapillary component.
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